​

LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?

OverviewChartTranscripts

LENZ Therapeutics Ownership Summary

LENZ Therapeutics is owned by 76.72% institutional investors, 2.76% insiders, and 20.51% retail investors. Gsa capital partners llp is the largest institutional shareholder, holding 0% of LENZ shares.

LENZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLENZ Therapeutics76.72%2.76%20.51%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryBiotech Stocks 63.94%10.67%25.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gsa capital partners llp---
Jane street group---
Boothbay fund management---
Us bancorp \de\---
Rafferty asset management---
Ikarian capital---
Fortitude family office---
Virtus etf advisers---
Bml capital management---
Federated hermes---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gsa capital partners llp---
Jane street group---
Boothbay fund management---
Us bancorp \de\---
Rafferty asset management---
Ikarian capital---
Fortitude family office---
Virtus etf advisers---
Bml capital management---
Federated hermes---

Top Buyers

HolderShares% AssetsChange
Fortitude family office---9.00
Federated hermes---45.00
Us bancorp \de\---75.00
Virtus etf advisers---2.31K
Jane street group---7.94K

Top Sellers

HolderShares% AssetsChange
Ikarian capital---149.50K
Boothbay fund management---39.75K
Rafferty asset management---17.72K
Bml capital management---9.27K
Gsa capital partners llp---8.38K

Sold Out

HolderChange
Fortitude family office-9.00
Federated hermes-45.00
Us bancorp \de\-75.00
Virtus etf advisers-2.31K
Jane street group-7.94K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202510616.48%21,119,1009.06%761.51%575.56%2630.00%
Dec 31, 20249319.23%19,863,8136.02%731.54%5630.23%2025.00%
Sep 30, 20247823.81%18,735,645-0.94%681.26%43-4.44%16300.00%
Jun 30, 20246314.55%18,913,54216.53%731.84%45-18.18%4-
Mar 31, 202455-16,230,517-63-55---

Recent Insider Transactions

DateNameRoleActivityValue
Jul 10, 2025Versant Venture Capital VI, L.P.-Sell$6.51M
Jun 27, 2025Versant Venture Capital VI, L.P.-Sell$6.09M
Jun 18, 2025Versant Venture Capital VI, L.P.-Sell$3.00M
Jun 20, 2025Versant Venture Capital VI, L.P.-Sell$3.06M
Jun 20, 2025Versant Venture Capital VI, L.P.-Sell$4.05M

Insider Transactions Trends

DateBuySell
2025 Q2-4
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q22-

LENZ Ownership FAQ

Who Owns LENZ Therapeutics?

LENZ Therapeutics shareholders are primarily institutional investors at 76.72%, followed by 2.76% insiders and 20.52% retail investors. The average institutional ownership in LENZ Therapeutics's industry, Biotech Stocks , is 63.94%, which LENZ Therapeutics exceeds.

Who owns the most shares of LENZ Therapeutics?

LENZ Therapeutics’s largest shareholders are Gsa capital partners llp (0 shares, 0%), Jane street group (0 shares, 0%), and Boothbay fund management (0 shares, 0%). Together, they hold 0% of LENZ Therapeutics’s total shares outstanding.

Does Blackrock own LENZ Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LENZ Therapeutics.

Who is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested?

Gsa capital partners llp is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 LENZ Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools